share_log

美国生物制药巨头Amgen将收购创新药开发公司ChemoCentryx

Us biopharmaceutical giant Amgen to acquire innovative drug development company ChemoCentryx

Moomoo 24/7 ·  Aug 4, 2022 08:09
Us biopharmaceutical giant Amgen will buy innovative drug developer ChemoCentryx for $52 a share in cash.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment